Refine by MP, party, committee, province, or result type.
Health committee I'd like to say to Mr. Thériault that some key partners are missing from that roundtable, and I mean the provinces.
June 4th, 2021Committee meeting
Anie Perrault
Health committee I can answer that. Do you want to go ahead, Paul, on this one?
June 4th, 2021Committee meeting
Anie Perrault
Health committee Okay. Actually, Mr. Van Bynen, I applaud the investment that the Canadian government has made recently in the sector. My point today is that the ecosystem is much larger than just drug prices. It's about much more than that. We don't have a Canadian life sciences strategy right
June 4th, 2021Committee meeting
Anie Perrault
Health committee Thank you for the question, Mr. d'Entremont. Investments come from a number of sectors. At BIOQuébec, our members are not large pharmaceutical companies. They are biotechnology companies that do clinical and preclinical studies. They are part of the ecosystem. However, the ecos
June 4th, 2021Committee meeting
Anie Perrault
Health committee I'll tell you what I think about it and I'm also going to ask Mr. Lévesque to comment and tell us what he would do, as the head of a company, if he had to make decisions about drugs that he was working on. Market access is a key factor in the innovation chain. When you restrict
June 4th, 2021Committee meeting
Anie Perrault
Health committee I'm assuming that question is for me?
June 4th, 2021Committee meeting
Anie Perrault
Health committee In our opinion, the current reform clearly seems to have been designed in a vacuum, whereas our ecosystem works horizontally. The ecosystem is a chain of innovation from research in academia to, hopefully, the commercialization of new drugs. Along that chain, there are many playe
June 4th, 2021Committee meeting
Anie Perrault
Health committee Thank you. As long as you stop the clock for these six minutes, I'm going to be fine. Regulating drug prices is the responsibility of the provinces, which are in charge of health care and, in Quebec, a public drug insurance program. In our opinion, there are already ways to m
June 4th, 2021Committee meeting
Anie Perrault
Health committee Thank you, Mr. Chair. Ladies and gentlemen of the committee, thank you for welcoming us and allowing us to participate in this important and strategic discussion. My name is Anie Perrault, and I am the chief executive officer of BIOQuébec. BIOQuébec is an industry associati
June 4th, 2021Committee meeting
Anie Perrault